Cumberland Pharmaceuticals (CPIX)
(Delayed Data from NSDQ)
$1.22 USD
-0.06 (-4.69%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.27 +0.05 (4.10%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
CPIX 1.22 -0.06(-4.69%)
Will CPIX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CPIX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for CPIX
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2024 Earnings Call Transcript
Cumberland: Q2 Earnings Snapshot
Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024
Cumberland Pharmaceuticals Non-GAAP EPS of $0.01, revenue of $9.9M
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTS